• Most Popular
  • Most Shared

ZymoGenetics' partner Merck Serono gets FDA nod for lupus trial

Tue Jan 15, 2008 6:22am EST

Stocks

   

Jan 15 (Reuters) - ZymoGenetics Inc (ZGEN.O) said its partner Merck Serono, German drugmaker Merck KGaA's (MRCG.DE) affiliate, received approval from U.S. health regulators for the design of a late-stage lupus trial testing the drug atacicept.

Stocks  |  Regulatory News

The drug is already in another late-stage trial for lupus nephritis, ZymoGenetics said in a statement.

ZymoGenetics said Merck Serono is the sponsor for both clinical studies. (Reporting by Varsha Tickoo in Bangalore; Editing by Himani Sarkar)

Stocks
Regulatory News


More from Reuters

This heart-wrenching picture of a mother and child at an an emergency feeding centre in in Tahoua, Niger, won international acclaim for incorporating beauty, horror and despair. Taken on August 1, 2005 by Finbarr O'Reilly.

Pictures of the Decade

    Pictures
    A customer is served at a counter inside a foreign exchange store displaying a poster of various banknotes including the Chinese yuan or renminbi (RMB) in Hong Kong November 20, 2009. REUTERS/Bobby Yip
    OUTLOOK 2010:

    Be careful what you wish for

    Pressure on China to loosen its grip on the yuan will continue but the U.S. should tread carefully. Here are five world market issues to watch.  Full Article 

    Global Markets
    Aurora, a 20-year-old Beluga whale, swims with her newborn calf after giving birth at the Vancouver Aquarium in Vancouver, British Columbia June 7, 2009. REUTERS/Andy Clark

    365 days for the doomed

    From polar bears to emperor penguins, endangered species will get top online billing in 2010 during the Year of Biodiversity.  Full Article 

    Green Business